NM 100120
Latest Information Update: 11 Feb 2008
At a glance
- Originator NexMed
- Class Local anaesthetics
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 12 Feb 2004 Preclinical trials in Pain in USA (Transdermal)